{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:27:04Z","timestamp":1788200824429,"version":"build-2803163510"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12015-025-10990-w","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:42:29Z","timestamp":1760056949000},"page":"144-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A New Vision for Ocular Disease: Stem Cell Strategies in Regenerative Ophthalmology"],"prefix":"10.1007","volume":"22","author":[{"given":"Sadhnakumari","family":"Chourasiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratixa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Santhana","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"2","key":"10990_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.aopr.2024.02.001","volume":"4","author":"Y Niu","year":"2024","unstructured":"Niu, Y., Ji, J., Yao, K., & Fu, Q. (2024). Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges. Advances in Ophthalmology Practice and Research, 4(2), 52\u201364. https:\/\/doi.org\/10.1016\/j.aopr.2024.02.001","journal-title":"Advances in Ophthalmology Practice and Research"},{"issue":"2","key":"10990_CR2","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne, R. R. A., Steinmetz, J. D., Saylan, M., et al. (2021). Trends in prevalence of blindness and vision impairment over the past 30 years: Findings from the global burden of disease study. The Lancet Global Health, 9(2), e130\u2013e143. https:\/\/doi.org\/10.1016\/S2214-109X(20)30425-3","journal-title":"The Lancet Global Health"},{"issue":"12","key":"10990_CR3","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman, S. R., Bourne, R. R. A., Resnikoff, S., et al. (2017). Global causes of blindness and distance vision impairment 1990\u20132020: A systematic review and meta-analysis. The Lancet Global Health, 5(12), e1221\u2013e1234. https:\/\/doi.org\/10.1016\/S2214-109X(17)30393-5","journal-title":"The Lancet Global Health"},{"issue":"9","key":"10990_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamaophthalmol.2019.2235","volume":"137","author":"JR Ehrlich","year":"2019","unstructured":"Ehrlich, J. R., Stagg, B. C., Andrews, C., et al. (2019). Vision impairment and subjective cognitive decline in older adults. JAMA Ophthalmology, 137(9), 989\u2013995. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.2235","journal-title":"JAMA Ophthalmology"},{"key":"10990_CR5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1186\/s12913-020-05820-8","volume":"20","author":"C Vela","year":"2020","unstructured":"Vela, C., Samson, E., Zunzunegui, M. V., et al. (2020). Eye care utilization by older adults in low, middle and high income countries. BMC Health Services Research, 20, 972. https:\/\/doi.org\/10.1186\/s12913-020-05820-8","journal-title":"BMC Health Services Research"},{"issue":"3","key":"10990_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ICO.0000000000001903","volume":"38","author":"SX Deng","year":"2019","unstructured":"Deng, S. X., Borderie, V., Chan, C. C., et al. (2019). Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea, 38(3), 364\u2013375. https:\/\/doi.org\/10.1097\/ICO.0000000000001903","journal-title":"Cornea"},{"issue":"4","key":"10990_CR7","first-page":"728","volume":"73","author":"A Sharma","year":"2025","unstructured":"Sharma, A., Mehta, B. B., Sheth, R., et al. (2025). Emerging approaches for ocular surface and corneal regeneration: Clinical translation of stem cells and biomaterials. Indian Journal of Ophthalmology, 73(4), 728\u2013737.","journal-title":"Indian Journal of Ophthalmology"},{"key":"10990_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","volume":"63","author":"MF Dias","year":"2018","unstructured":"Dias, M. F., Joo, K., Kemp, J. A., et al. (2018). Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives. Progress in Retinal and Eye Research, 63, 107\u2013131. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.004","journal-title":"Progress in Retinal and Eye Research"},{"issue":"18","key":"10990_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: A review. Journal of The American Medical Association, 311(18), 1901\u20131911. https:\/\/doi.org\/10.1001\/jama.2014.3192","journal-title":"Journal of The American Medical Association"},{"key":"10990_CR10","doi-asserted-by":"publisher","DOI":"10.59613\/nbhme628","author":"AP Ratna","year":"2024","unstructured":"Ratna, A. P., Ginting, K. H., Subroto, I., Santoso, A., & Purwoko, R. Y. (2024). Regenerative medicine: Tissue engineering and stem cell therapy. Join: Journal of Social Science. https:\/\/doi.org\/10.59613\/nbhme628","journal-title":"Join: Journal of Social Science"},{"key":"10990_CR11","doi-asserted-by":"publisher","first-page":"1269577","DOI":"10.3389\/fnins.2024.1269577","volume":"18","author":"J Wang","year":"2024","unstructured":"Wang, J., Deng, G., Wang, S., Li, S., Song, P., Lin, K., Xu, X., & He, Z. (2024). Enhancing regenerative medicine: The crucial role of stem cell therapy. Frontiers in Neuroscience, 18, 1269577. https:\/\/doi.org\/10.3389\/fnins.2024.1269577","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10990_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016018251","volume":"27","author":"MS Javaid","year":"2017","unstructured":"Javaid, M. S., Ashfaq, U. A., & Masoud, M. S. (2017). Potential of stem cells as regenerative medicine: From preface to advancements. Critical Reviews in Eukaryotic Gene Expression, 27(1), 1\u201317. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2016018251","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"issue":"4","key":"10990_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"L Da Cruz","year":"2018","unstructured":"Da Cruz, L., Fynes, K., Georgiadis, O., et al. (2018). Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nature Biotechnology, 36(4), 328\u2013337. https:\/\/doi.org\/10.1038\/nbt.4114","journal-title":"Nature Biotechnology"},{"issue":"2","key":"10990_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/1673-5374.200793","volume":"12","author":"I Aharony","year":"2017","unstructured":"Aharony, I., Michowiz, S., & Goldenberg-Cohen, N. (2017). The promise of stem cell-based therapeutics in ophthalmology. Neural Regeneration Research, 12(2), 173\u2013180. https:\/\/doi.org\/10.4103\/1673-5374.200793","journal-title":"Neural Regeneration Research"},{"key":"10990_CR15","doi-asserted-by":"publisher","DOI":"10.51271\/ankmj-0037","author":"A Erdem","year":"2025","unstructured":"Erdem, A., Beyo\u011flu, A., & Acar Duyan, \u015e. N. (2025). Stem cell therapies in ophthalmology. Ankyra Medical Journal. https:\/\/doi.org\/10.51271\/ankmj-0037","journal-title":"Ankyra Medical Journal"},{"key":"10990_CR16","unstructured":"Ng, T. K., & Yung, J. S. (2015). Research progress and human clinical trials of mesenchymal stem cells in ophthalmology: A mini review. [Journal name not provided]."},{"issue":"90","key":"10990_CR17","first-page":"241","volume":"27","author":"J Aznar","year":"2016","unstructured":"Aznar, J., & Tudela, J. (2016). Use of embryonic stem cells to treat severe eye diseases. Cuadernos de Bio\u00e9tica: Revista Oficial de la Asociaci\u00f3n Espa\u00f1ola de Bio\u00e9tica y \u00c9tica M\u00e9dica, 27(90), 241\u2013247.","journal-title":"Cuadernos de Bio\u00e9tica: Revista Oficial de la Asociaci\u00f3n Espa\u00f1ola de Bio\u00e9tica y \u00c9tica M\u00e9dica"},{"issue":"5","key":"10990_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4252\/wjsc.v13.i5.366","volume":"13","author":"G Miotti","year":"2021","unstructured":"Miotti, G., Parodi, P. C., & Zeppieri, M. (2021). Stem cell therapy in ocular pathologies in the past 20 years. World Journal of Stem Cells, 13(5), 366\u2013385. https:\/\/doi.org\/10.4252\/wjsc.v13.i5.366","journal-title":"World Journal of Stem Cells"},{"key":"10990_CR19","doi-asserted-by":"publisher","first-page":"2361763","DOI":"10.1155\/2016\/2361763","volume":"2016","author":"N Wu","year":"2016","unstructured":"Wu, N., Doorenbos, M., & Chen, D. F. (2016). Induced pluripotent stem cells: Development in the ophthalmologic field. Stem Cells International, 2016, 2361763. https:\/\/doi.org\/10.1155\/2016\/2361763","journal-title":"Stem Cells International"},{"key":"10990_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/978-3-319-17121-0_73","volume":"854","author":"Y Li","year":"2016","unstructured":"Li, Y., Chan, L., Nguyen, H. V., & Tsang, S. H. (2016). Personalized medicine: Cell and gene therapy based on patient-specific iPSC-derived retinal pigment epithelium cells. Advances in Experimental Medicine and Biology, 854, 549\u2013555. https:\/\/doi.org\/10.1007\/978-3-319-17121-0_73","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"5","key":"10990_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.stem.2021.02.006","volume":"28","author":"K Achberger","year":"2021","unstructured":"Achberger, K., et al. (2021). 3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degeneration. Cell Stem Cell, 28(5), 846\u2013862e8. https:\/\/doi.org\/10.1016\/j.stem.2021.02.006","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10990_CR22","doi-asserted-by":"publisher","first-page":"112345","DOI":"10.1016\/j.celrep.2024.112345","volume":"40","author":"R Singh","year":"2024","unstructured":"Singh, R., et al. (2024). Human iPSC-based disease modeling studies identify a common mechanistic defect and potential therapies for AMD and related macular dystrophies. Cell Reports, 40(3), 112345. https:\/\/doi.org\/10.1016\/j.celrep.2024.112345","journal-title":"Cell Reports"},{"issue":"8","key":"10990_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jfo.2015.05.003","volume":"38","author":"C Roubeix","year":"2015","unstructured":"Roubeix, C., Denoyer, A., Brignole-Baudouin, F., & Baudouin, C. (2015). [Mesenchymal stem cell therapy, a new hope for eye disease]. Journal Fran\u00e7ais d\u2019Ophtalmologie, 38(8), 764\u2013775. https:\/\/doi.org\/10.1016\/j.jfo.2015.05.003","journal-title":"Journal Fran\u00e7ais d\u2019Ophtalmologie"},{"issue":"Suppl 1","key":"10990_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0138-4","volume":"15","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Coulson-Thomas, V. J., Ferreira, T. G., et al. (2015). Mesenchymal stem cells for treating ocular surface diseases. BMC Ophthalmology, 15(Suppl 1), Article 155. https:\/\/doi.org\/10.1186\/s12886-015-0138-4","journal-title":"BMC Ophthalmology"},{"key":"10990_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12015-017-9750-4","volume":"13","author":"A Cislo-Pakuluk","year":"2017","unstructured":"Cislo-Pakuluk, A., & Marycz, K. (2017). A promising tool in retina regeneration: Current perspectives and challenges when using mesenchymal progenitor stem cells in veterinary and human ophthalmological applications. Stem Cell Reviews and Reports, 13, 598\u2013602. https:\/\/doi.org\/10.1007\/s12015-017-9750-4","journal-title":"Stem Cell Reviews and Reports"},{"issue":"4","key":"10990_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jtos.2019.07.005","volume":"17","author":"S Shukla","year":"2019","unstructured":"Shukla, S., Mittal, S. K., Foulsham, W., et al. (2019). Therapeutic efficacy of different routes of mesenchymal stem cell administration in corneal injury. The Ocular Surface, 17(4), 729\u2013736. https:\/\/doi.org\/10.1016\/j.jtos.2019.07.005","journal-title":"The Ocular Surface"},{"key":"10990_CR27","first-page":"706","volume":"26","author":"E Ghazaryan","year":"2020","unstructured":"Ghazaryan, E., et al. (2020). The antiangiogenic properties of adipose-derived mesenchymal stem\/stromal cells in corneal neovascularization in a rabbit model. Molecular Vision, 26, 706\u2013716. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7134242\/","journal-title":"Molecular Vision"},{"key":"10990_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12967-017-1183-y","volume":"15","author":"Z Tang","year":"2017","unstructured":"Tang, Z., Zhang, Y., Wang, Y., et al. (2017). Progress of stem\/progenitor cell-based therapy for retinal degeneration. Journal of Translational Medicine, 15, 99. https:\/\/doi.org\/10.1186\/s12967-017-1183-y","journal-title":"Journal of Translational Medicine"},{"issue":"9","key":"10990_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-020-02955-3","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Tang, Z., & Gu, P. (2020). Stem\/progenitor cell-based transplantation for retinal degeneration: A review of clinical trials. Cell Death & Disease, 11(9), 793. https:\/\/doi.org\/10.1038\/s41419-020-02955-3","journal-title":"Cell Death & Disease"},{"key":"10990_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40135-019-00195-z","volume":"7","author":"AM Aladdad","year":"2019","unstructured":"Aladdad, A. M., & Kador, K. E. (2019). Adult stem cells, tools for repairing the retina. Current Ophthalmology Reports, 7, 21\u201329. https:\/\/doi.org\/10.1007\/s40135-019-00195-z","journal-title":"Current Ophthalmology Reports"},{"issue":"6","key":"10990_CR31","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1167\/iovs.17-23646","volume":"59","author":"BT McLelland","year":"2018","unstructured":"McLelland, B. T., Lin, B., Mathur, A., Aramant, R. B., Thomas, B. B., Nistor, G., Keirstead, H. S., Seiler, M. J., & Humayun, M. S. (2018). Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Investigative Ophthalmology & Visual Science, 59(6), 2586\u20132593. https:\/\/pubmed.ncbi.nlm.nih.gov\/29847666\/","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"12","key":"10990_CR32","first-page":"3011","volume":"30","author":"H Zhou","year":"2022","unstructured":"Zhou, H., Wang, Y., Chang, R., Wang, J., Zhou, Y., & Liu, Y. (2022). Photoreceptor laminin drives differentiation of human pluripotent stem cells to photoreceptor progenitors that partially restore retina function. Molecular Therapy, 30(12), 3011\u20133024.","journal-title":"Molecular Therapy"},{"key":"10990_CR33","doi-asserted-by":"publisher","unstructured":"Nurkovi\u0107, J., Vojinovi\u0107, R., & Doli\u0107anin, Z. (2020). Corneal stem cells as a source of regenerative cell-based therapy. Stem Cells International, 2020, Article 8813447. https:\/\/doi.org\/10.1155\/2020\/8813447","DOI":"10.1155\/2020\/8813447"},{"issue":"2","key":"10990_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5114\/ceji.2017.69360","volume":"42","author":"A D\u0105browska","year":"2017","unstructured":"D\u0105browska, A., & Skopi\u0144ski, P. (2017). Stem cells in regenerative medicine \u2013 from laboratory to clinical application \u2013 the eye. Central European Journal of Immunology, 42(2), 173\u2013180. https:\/\/doi.org\/10.5114\/ceji.2017.69360","journal-title":"Central European Journal of Immunology"},{"issue":"11","key":"10990_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/stcltm\/szad058","volume":"12","author":"C Bonnet","year":"2023","unstructured":"Bonnet, C., Gonz\u00e1lez, S., & Deng, S. X. (2023). Ocular surface regeneration by limbal stem cells therapies: State of the art, challenges, and perspectives. Stem Cells Translational Medicine, 12(11), 714\u2013719. https:\/\/doi.org\/10.1093\/stcltm\/szad058","journal-title":"Stem Cells Translational Medicine"},{"key":"10990_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s40135-018-0187-y","volume":"6","author":"J Cabral-Macias","year":"2018","unstructured":"Cabral-Macias, J., Martinez, J. D., Naranjo, A., et al. (2018). Update on the surgical reconstruction of ocular surface in eyes with limbal stem cell deficiency. Current Ophthalmology Reports, 6, 256\u2013265. https:\/\/doi.org\/10.1007\/s40135-018-0187-y","journal-title":"Current Ophthalmology Reports"},{"key":"10990_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","volume":"14","author":"B Mead","year":"2015","unstructured":"Mead, B., Berry, M., Logan, A., Scott, R. A., Leadbeater, W., & Scheven, B. A. (2015). Stem cell treatment of degenerative eye disease. Stem Cell Research, 14, 243\u2013257. https:\/\/doi.org\/10.1016\/j.scr.2015.02.003","journal-title":"Stem Cell Research"},{"issue":"1","key":"10990_CR38","doi-asserted-by":"publisher","first-page":"45181","DOI":"10.1038\/s41598-017-06635-7","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang, W., Wang, Y., Kong, J., Dong, M., Duan, H., & Chen, S. (2017). Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Scientific Reports, 7(1), 45181. https:\/\/doi.org\/10.1038\/s41598-017-06635-7","journal-title":"Scientific Reports"},{"key":"10990_CR39","doi-asserted-by":"publisher","unstructured":"Wang, L., Zhang, Z., Wang, X., Zhang, R., Li, C., Xu, Y., \u2026 Chen, J. (2018). Transplantation of neural stem cells derived from human induced pluripotent stem cells in a rat model of traumatic brain injury. Stem Cell Reports, 10(4), 1367\u20131381. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.017.","DOI":"10.1016\/j.stemcr.2018.01.017."},{"issue":"2","key":"10990_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2174\/1567205013666160314145347","volume":"14","author":"P Bali","year":"2017","unstructured":"Bali, P., Lahiri, D. K., Banik, A., Nehru, B., & Anand, A. (2017). Potential for stem cell therapy in alzheimer\u2019s disease: Do neurotrophic factors play critical role? Current Alzheimer Research, 14(2), 208\u2013220. https:\/\/doi.org\/10.2174\/1567205013666160314145347","journal-title":"Current Alzheimer Research"},{"key":"10990_CR41","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan, X. L., Zhang, Y., Li, X., et al. (2020). Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell and Molecular Life Sciences, 77, 2771\u20132794. https:\/\/doi.org\/10.1007\/s00018-020-03454-6","journal-title":"Cell and Molecular Life Sciences"},{"issue":"1","key":"10990_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/CIRCRESAHA.115.305373","volume":"118","author":"CP Hodgkinson","year":"2016","unstructured":"Hodgkinson, C. P., Bareja, A., Gomez, J. A., & Dzau, V. J. (2016). Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circulation Research, 118(1), 95\u2013107. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.305373","journal-title":"Circulation Research"},{"key":"10990_CR43","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/CIRCRESAHA.117.311925","volume":"121","author":"SE Epstein","year":"2017","unstructured":"Epstein, S. E., Luger, D., & Lipinski, M. J. (2017). Paracrine-mediated systemic anti-inflammatory activity of intravenously administered mesenchymal stem cells: A transformative strategy for cardiac stem cell therapeutics. Circulation Research, 121, 1044\u20131046. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311925","journal-title":"Circulation Research"},{"issue":"2","key":"10990_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics14020381","volume":"14","author":"R Alvites","year":"2022","unstructured":"Alvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., & Maur\u00edcio, A. C. (2022). Mesenchymal stem\/stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics, 14(2), 381. https:\/\/doi.org\/10.3390\/pharmaceutics14020381","journal-title":"Pharmaceutics"},{"key":"10990_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13578-024-01277-7","volume":"14","author":"D Li","year":"2024","unstructured":"Li, D., Li, D., Wang, Z., et al. (2024). Signaling pathways activated and regulated by stem cell-derived exosome therapy. Cell & Bioscience, 14, 105. https:\/\/doi.org\/10.1186\/s13578-024-01277-7","journal-title":"Cell & Bioscience"},{"issue":"7","key":"10990_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/jcm8071025","volume":"8","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2019). The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity. Journal of Clinical Medicine, 8(7), 1025. https:\/\/doi.org\/10.3390\/jcm8071025","journal-title":"Journal of Clinical Medicine"},{"key":"10990_CR47","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss, A. R. R., & Dahlke, M. H. (2019). Immunomodulation by mesenchymal stem cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs. Frontiers in Immunology, 10, 1191. https:\/\/doi.org\/10.3389\/fimmu.2019.01191","journal-title":"Frontiers in Immunology"},{"key":"10990_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/nyas.12815","volume":"1351","author":"A Uccelli","year":"2015","unstructured":"Uccelli, A., & Rosbo, N. K. (2015). The immunomodulatory function of mesenchymal stem cells: Mode of action and pathways. Annals of the New York Academy of Sciences, 1351, 114\u2013126. https:\/\/doi.org\/10.1111\/nyas.12815","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"8","key":"10990_CR49","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M., & Shah, K. (2020). Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends in Pharmacological Sciences, 41(8), 653\u2013664. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"12","key":"10990_CR50","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.4252\/wjsc.v11.i12.1104","volume":"11","author":"GE Tian","year":"2019","unstructured":"Tian, G. E., Zhou, J. T., Liu, X. J., & Huang, Y. C. (2019). Mechanoresponse of stem cells for vascular repair. World Journal of Stem Cells, 11(12), 1104\u20131114. https:\/\/doi.org\/10.4252\/wjsc.v11.i12.1104","journal-title":"World Journal of Stem Cells"},{"issue":"2","key":"10990_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/biof.1717","volume":"47","author":"S Ghodrat","year":"2021","unstructured":"Ghodrat, S., Hoseini, S. J., Asadpour, S., Nazarnezhad, S., Alizadeh Eghtedar, F., & Kargozar, S. (2021). Stem cell-based therapies for cardiac diseases: The critical role of angiogenic exosomes. Biofactors, 47(2), 270\u2013291. https:\/\/doi.org\/10.1002\/biof.1717","journal-title":"Biofactors"},{"issue":"1","key":"10990_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/bmb\/ldw017","volume":"118","author":"SC Slater","year":"2016","unstructured":"Slater, S. C., Carrabba, M., & Madeddu, P. (2016). Vascular stem cells\u2014potential for clinical application. British Medical Bulletin, 118(1), 127\u2013137. https:\/\/doi.org\/10.1093\/bmb\/ldw017","journal-title":"British Medical Bulletin"},{"key":"10990_CR53","doi-asserted-by":"publisher","first-page":"633300","DOI":"10.3389\/fcvm.2021.633300","volume":"8","author":"W Shi","year":"2021","unstructured":"Shi, W., Xin, Q., Yuan, R., Yuan, Y., Cong, W., & Chen, K. (2021). Neovascularization: The main mechanism of MSCs in ischemic heart disease therapy. Frontiers in Cardiovascular Medicine, 8, 633300. https:\/\/doi.org\/10.3389\/fcvm.2021.633300","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10990_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-94-017-7273-0_6","volume":"15","author":"X Guo","year":"2015","unstructured":"Guo, X., Chen, J., Li, Z., & Xi, R. (2015). Signaling pathways regulating stem cells. Stem Cells and Cancer Stem Cells, 15, 113\u2013127. https:\/\/doi.org\/10.1007\/978-94-017-7273-0_6","journal-title":"Stem Cells and Cancer Stem Cells"},{"key":"10990_CR55","doi-asserted-by":"publisher","unstructured":"Fagnocchi, L., Mazzoleni, S., & Zippo, A. (2016). Integration of signaling pathways with the epigenetic machinery in the maintenance of stem cells. Stem Cells International, 2016, Article 8652748. https:\/\/doi.org\/10.1155\/2016\/8652748","DOI":"10.1155\/2016\/8652748"},{"issue":"1","key":"10990_CR56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004765","volume":"95","author":"WH Matsui","year":"2016","unstructured":"Matsui, W. H. (2016). Cancer stem cell signaling pathways. Medicine, 95(1), Article e4765. https:\/\/doi.org\/10.1097\/MD.0000000000004765","journal-title":"Medicine"},{"issue":"12","key":"10990_CR57","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrm.2017.108","volume":"18","author":"KH Vining","year":"2017","unstructured":"Vining, K. H., & Mooney, D. J. (2017). Mechanical forces direct stem cell behaviour in development and regeneration. Nature Reviews Molecular Cell Biology, 18(12), 728\u2013742. https:\/\/doi.org\/10.1038\/nrm.2017.108","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"8","key":"10990_CR58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tcb.2017.04.002","volume":"27","author":"A Werner","year":"2017","unstructured":"Werner, A., Manford, A., & Rap\u00e9, M. (2017). Ubiquitin-dependent regulation of stem cell biology. Trends in Cell Biology, 27(8), 568\u2013579. https:\/\/doi.org\/10.1016\/j.tcb.2017.04.002","journal-title":"Trends in Cell Biology"},{"key":"10990_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2016.06.001","volume":"43","author":"C Chen","year":"2016","unstructured":"Chen, C., Fingerhut, J. M., & Yamashita, Y. (2016). The ins(ide) and outs(ide) of asymmetric stem cell division. Current Opinion in Cell Biology, 43, 1\u20136. https:\/\/doi.org\/10.1016\/j.ceb.2016.06.001","journal-title":"Current Opinion in Cell Biology"},{"issue":"17","key":"10990_CR60","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/scd.2015.0117","volume":"24","author":"A Wanet","year":"2015","unstructured":"Wanet, A., Arnould, T., Najimi, M., & Renard, P. (2015). Connecting mitochondria, metabolism, and stem cell fate. Stem Cells and Development, 24(17), 1957\u20131971. https:\/\/doi.org\/10.1089\/scd.2015.0117","journal-title":"Stem Cells and Development"},{"key":"10990_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3978\/j.issn.2306-9759.2015.05.02","volume":"2","author":"BN Hannafon","year":"2015","unstructured":"Hannafon, B. N., & Ding, W. (2015). Cancer stem cells and exosome signaling. Stem Cell Investigation, 2, 11. https:\/\/doi.org\/10.3978\/j.issn.2306-9759.2015.05.02","journal-title":"Stem Cell Investigation"},{"issue":"7","key":"10990_CR62","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cbin.10742","volume":"41","author":"B Derku\u015f","year":"2017","unstructured":"Derku\u015f, B., Emregul, K. C., & Emregul, E. (2017). A new approach in stem cell research\u2014Exosomes: Their mechanism of action via cellular pathways. Cell Biology International, 41(7), 758\u2013769. https:\/\/doi.org\/10.1002\/cbin.10742","journal-title":"Cell Biology International"},{"issue":"5","key":"10990_CR63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.amjms.2018.07.006","volume":"356","author":"K Yuan","year":"2018","unstructured":"Yuan, K., Zhang, P., Qi, S., Zhu, Q., & Li, P. (2018). Emerging role for exosomes in the progress of stem cell research. The American Journal of the Medical Sciences, 356(5), 481\u2013486. https:\/\/doi.org\/10.1016\/j.amjms.2018.07.006","journal-title":"The American Journal of the Medical Sciences"},{"key":"10990_CR64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12951-025-03300-6","volume":"23","author":"D Yoo","year":"2025","unstructured":"Yoo, D., Jung, S. Y., Go, D., et al. (2025). Functionalized extracellular vesicles of mesenchymal stem cells for regenerative medicine. Journal Of Nanobiotechnology, 23, 219. https:\/\/doi.org\/10.1186\/s12951-025-03300-6","journal-title":"Journal Of Nanobiotechnology"},{"issue":"1","key":"10990_CR65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/08820538.2017.1353834","volume":"33","author":"J Yin","year":"2018","unstructured":"Yin, J., & Jurkunas, U. (2018). Limbal stem cell transplantation and complications. Seminars in Ophthalmology, 33(1), 134\u2013141. https:\/\/doi.org\/10.1080\/08820538.2017.1353834","journal-title":"Seminars in Ophthalmology"},{"issue":"3","key":"10990_CR66","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P., Nichols, K. K., Akpek, E. K., et al. (2017). TFOS DEWS II definition and classification report. The Ocular Surface, 15(3), 276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"The Ocular Surface"},{"key":"10990_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","volume":"19","author":"M Moller-Hansen","year":"2021","unstructured":"Moller-Hansen, M., Larsen, A. C., Toft, P. B., et al. (2021). Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. Ocular Surface, 19, 43\u201352. https:\/\/doi.org\/10.1016\/j.jtos.2020.11.013","journal-title":"Ocular Surface"},{"issue":"2","key":"10990_CR68","doi-asserted-by":"publisher","first-page":"eabj9617","DOI":"10.1126\/sciadv.abj9617","volume":"8","author":"T Zhou","year":"2022","unstructured":"Zhou, T., He, C., Lai, P., et al. (2022). MiR-204-containing exosomes ameliorate GVHD-associated dry eye disease. Science Advances, 8(2), eabj9617. https:\/\/doi.org\/10.1126\/sciadv.abj9617","journal-title":"Science Advances"},{"key":"10990_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40662-016-0033-y","volume":"3","author":"F Arnalich-Montiel","year":"2016","unstructured":"Arnalich-Montiel, F., Alio, D. B. J., & Alio, J. L. (2016). Corneal surgery in keratoconus: Which type, which technique, which outcomes? Eye and Vision, 3, 2. https:\/\/doi.org\/10.1186\/s40662-016-0033-y","journal-title":"Eye and Vision"},{"issue":"2","key":"10990_CR70","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","volume":"134","author":"P Gain","year":"2016","unstructured":"Gain, P., Jullienne, R., He, Z., et al. (2016). Global survey of corneal transplantation and eye banking. JAMA Ophthalmology, 134(2), 167\u2013173. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.4776","journal-title":"JAMA Ophthalmology"},{"key":"10990_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2017.10.026","volume":"186","author":"DBJ Alio","year":"2018","unstructured":"Alio, D. B. J., El, Z. M., Azaar, A., et al. (2018). Corneal stroma enhancement with decellularized stromal laminas with or without stem cell recellularization for advanced keratoconus. American Journal of Ophthalmology, 186, 47\u201358. https:\/\/doi.org\/10.1016\/j.ajo.2017.10.026","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10990_CR72","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/ICO.0000000000001228","volume":"36","author":"DBJ Alio","year":"2017","unstructured":"Alio, D. B. J., El, Z. M., de Miguel, M. P., et al. (2017). Cellular therapy with human autologous adipose-derived adult stem cells for advanced keratoconus. Cornea, 36(8), 952\u2013960. https:\/\/doi.org\/10.1097\/ICO.0000000000001228","journal-title":"Cornea"},{"key":"10990_CR73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajo.2019.02.009","volume":"203","author":"JL Alio","year":"2019","unstructured":"Alio, J. L., Alio, D. B. J., El, Z. M., et al. (2019). Regenerative surgery of the corneal stroma for advanced keratoconus: 1-year outcomes. American Journal of Ophthalmology, 203, 53\u201368. https:\/\/doi.org\/10.1016\/j.ajo.2019.02.009","journal-title":"American Journal of Ophthalmology"},{"key":"10990_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003152","author":"ZM El","year":"2022","unstructured":"El, Z. M., Alio, D. B. J., Mingo, D., et al. (2022). Corneal stromal densitometry evolution in a clinical model of cellular therapy for advanced keratoconus. Cornea. https:\/\/doi.org\/10.1097\/ICO.0000000000003152","journal-title":"Cornea"},{"key":"10990_CR75","doi-asserted-by":"publisher","first-page":"650724","DOI":"10.3389\/fmed.2021.650724","volume":"8","author":"ZM El","year":"2021","unstructured":"El, Z. M., Alio, J. L., Alio, D. B. J., et al. (2021). Corneal stromal regeneration: A review of human clinical studies in keratoconus treatment. Frontiers in Medicine, 8, 650724. https:\/\/doi.org\/10.3389\/fmed.2021.650724","journal-title":"Frontiers in Medicine"},{"issue":"11","key":"10990_CR76","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMoa1712770","volume":"378","author":"S Kinoshita","year":"2018","unstructured":"Kinoshita, S., Koizumi, N., Ueno, M., et al. (2018). Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. New England Journal of Medicine, 378(11), 995\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa1712770","journal-title":"New England Journal of Medicine"},{"issue":"7594","key":"10990_CR77","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature17181","volume":"531","author":"H Lin","year":"2016","unstructured":"Lin, H., Ouyang, H., Zhu, J., et al. (2016). Lens regeneration using endogenous stem cells with gain of visual function. Nature, 531(7594), 323\u2013328. https:\/\/doi.org\/10.1038\/nature17181","journal-title":"Nature"},{"issue":"1","key":"10990_CR78","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1167\/iovs.16-20504","volume":"58","author":"Q Fu","year":"2017","unstructured":"Fu, Q., Qin, Z., Jin, X., et al. (2017). Generation of functional lentoid bodies from human induced pluripotent stem cells derived from urinary cells. Investigative Ophthalmology & Visual Science, 58(1), 517\u2013527. https:\/\/doi.org\/10.1167\/iovs.16-20504","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10990_CR79","doi-asserted-by":"publisher","first-page":"106921","DOI":"10.1016\/j.isci.2023.106921","volume":"26","author":"X Chen","year":"2023","unstructured":"Chen, X., Wang, H., Chen, H., et al. (2023). Lens regeneration in situ using hESCs-derived cells\u2014Similar to natural lens. IScience, 26(6), 106921. https:\/\/doi.org\/10.1016\/j.isci.2023.106921","journal-title":"IScience"},{"issue":"3","key":"10990_CR80","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/stem.1885","volume":"33","author":"DW Abu-Hassan","year":"2015","unstructured":"Abu-Hassan, D. W., Li, X., Ryan, E. I., et al. (2015). Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma. Stem Cells, 33(3), 751\u2013761. https:\/\/doi.org\/10.1002\/stem.1885","journal-title":"Stem Cells"},{"issue":"25","key":"10990_CR81","doi-asserted-by":"publisher","first-page":"E3492","DOI":"10.1073\/pnas.1604153113","volume":"113","author":"W Zhu","year":"2016","unstructured":"Zhu, W., Gramlich, O. W., & Laboissonniere, L. (2016). Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo. Proceedings of the National Academy of Sciences of the United States of America, 113(25), E3492\u2013E3500. https:\/\/doi.org\/10.1073\/pnas.1604153113","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10990_CR82","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1167\/iovs.16-20672","volume":"58","author":"W Zhu","year":"2017","unstructured":"Zhu, W., Jain, A., Gramlich, O. W., et al. (2017). Restoration of aqueous humor outflow following transplantation of iPSC-derived trabecular meshwork cells in a transgenic mouse model of glaucoma. Investigative Ophthalmology & Visual Science, 58(4), 2054\u20132062. https:\/\/doi.org\/10.1167\/iovs.16-20672","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10990_CR83","doi-asserted-by":"publisher","first-page":"e63677","DOI":"10.7554\/eLife.63677","volume":"10","author":"S Xiong","year":"2021","unstructured":"Xiong, S., Kumar, A., Tian, S., et al. (2021). Stem cell transplantation rescued a primary open-angle glaucoma mouse model. eLife, 10, e63677. https:\/\/doi.org\/10.7554\/eLife.63677","journal-title":"eLife"},{"key":"10990_CR84","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s42003-018-0227-z","volume":"1","author":"H Yun","year":"2018","unstructured":"Yun, H., Wang, Y., Zhou, Y., et al. (2018). Human stem cells home to and repair laser-damaged trabecular meshwork in a mouse model. Communications Biology, 1, 216. https:\/\/doi.org\/10.1038\/s42003-018-0227-z","journal-title":"Communications Biology"},{"issue":"1","key":"10990_CR85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13287-015-0168-0","volume":"6","author":"C Roubeix","year":"2015","unstructured":"Roubeix, C., Godefroy, D., Mias, C., et al. (2015). Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma. Stem Cell Research & Therapy, 6(1), 177. https:\/\/doi.org\/10.1186\/s13287-015-0168-0","journal-title":"Stem Cell Research & Therapy"},{"issue":"5","key":"10990_CR86","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1096\/fj.201902326R","volume":"34","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Xia, X., Yang, E., et al. (2020). Adipose-derived stem cells integrate into trabecular meshwork with glaucoma treatment potential. FASEB Journal, 34(5), 7160\u20137177. https:\/\/doi.org\/10.1096\/fj.201902326R","journal-title":"FASEB Journal"},{"key":"10990_CR87","doi-asserted-by":"publisher","first-page":"12251","DOI":"10.1038\/s41598-018-30834-7","volume":"8","author":"EJ Snider","year":"2018","unstructured":"Snider, E. J., Kubelick, K. P., Tweed, K., et al. (2018). Improving stem cell delivery to the trabecular meshwork using magnetic nanoparticles. Scientific Reports, 8, 12251. https:\/\/doi.org\/10.1038\/s41598-018-30834-7","journal-title":"Scientific Reports"},{"key":"10990_CR88","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.preteyeres.2022.101063","volume":"90","author":"SJ Coulon","year":"2022","unstructured":"Coulon, S. J., Schuman, J. S., Du, Y., et al. (2022). A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. Progress in Retinal and Eye Research, 90, 101063. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101063","journal-title":"Progress in Retinal and Eye Research"},{"issue":"7","key":"10990_CR89","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musia\u0142-Wysocka","year":"2019","unstructured":"Musia\u0142-Wysocka, A., Kot, M., & Majka, M. (2019). The pros and cons of mesenchymal stem cell-based therapies. Cell Transplantation, 28(7), 801\u2013812. https:\/\/doi.org\/10.1177\/0963689719837897","journal-title":"Cell Transplantation"},{"key":"10990_CR90","doi-asserted-by":"publisher","first-page":"e60831","DOI":"10.7554\/eLife.60831","volume":"10","author":"G Li","year":"2021","unstructured":"Li, G., Lee, C., Read, A. T., et al. (2021). Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis. eLife, 10, e60831. https:\/\/doi.org\/10.7554\/eLife.60831","journal-title":"eLife"},{"issue":"5","key":"10990_CR91","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1073\/pnas.1814889116","volume":"116","author":"G Li","year":"2019","unstructured":"Li, G., Lee, C., Agrahari, V., et al. (2019). In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model. Proceedings of the National Academy of Sciences, 116(5), 1714\u20131722. https:\/\/doi.org\/10.1073\/pnas.1814889116","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10990_CR92","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1167\/iovs.17-22175","volume":"58","author":"K Wang","year":"2017","unstructured":"Wang, K., Johnstone, M. A., Xin, C., et al. (2017). Estimating human trabecular meshwork stiffness by numerical modeling and advanced OCT imaging. Investigative Ophthalmology & Visual Science, 58(11), 4809\u20134817. https:\/\/doi.org\/10.1167\/iovs.17-22175","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9967","key":"10990_CR93","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz, S. D., Regillo, C. D., Lam, B. L., et al. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies. The Lancet, 385(9967), 509\u2013516. https:\/\/doi.org\/10.1016\/S0140-6736(14)61376-3","journal-title":"The Lancet"},{"issue":"1","key":"10990_CR94","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.oret.2020.06.012","volume":"5","author":"MG Nittala","year":"2021","unstructured":"Nittala, M. G., Uji, A., Velaga, S. B., et al. (2021). Effect of human central nervous system stem cell subretinal transplantation on progression of geographic atrophy secondary to nonneovascular age-related macular degeneration. Ophthalmology Retina, 5(1), 32\u201340. https:\/\/doi.org\/10.1016\/j.oret.2020.06.012","journal-title":"Ophthalmology Retina"},{"key":"10990_CR95","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41421-018-0053-y","volume":"4","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Xu, H. W., Wang, L., et al. (2018). Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration. Cell Discovery, 4, 50. https:\/\/doi.org\/10.1038\/s41421-018-0053-y","journal-title":"Cell Discovery"},{"issue":"6","key":"10990_CR96","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/cell.2018.0045","volume":"20","author":"A Oner","year":"2018","unstructured":"Oner, A., Gonen, Z. B., Sevim, D. G., et al. (2018). Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and stargardt\u2019s macular dystrophy: 6-month follow-up results of a phase 2 study. Cellular Reprogramming, 20(6), 329\u2013336. https:\/\/doi.org\/10.1089\/cell.2018.0045","journal-title":"Cellular Reprogramming"},{"key":"10990_CR97","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13287-020-02122-7","volume":"12","author":"A Tuekprakhon","year":"2021","unstructured":"Tuekprakhon, A., Sangkitporn, S., Trinavarat, A., et al. (2021). Intravitreal autologous mesenchymal stem cell transplantation: A non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Research & Therapy, 12, 52. https:\/\/doi.org\/10.1186\/s13287-020-02122-7","journal-title":"Stem Cell Research & Therapy"},{"issue":"16","key":"10990_CR98","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1089\/scd.2020.0037","volume":"29","author":"T Zhao","year":"2020","unstructured":"Zhao, T., Liang, Q., Meng, X., et al. (2020). Intravenous infusion of umbilical cord mesenchymal stem cells maintains and partially improves visual function in patients with advanced retinitis pigmentosa. Stem Cells and Development, 29(16), 1029\u20131037. https:\/\/doi.org\/10.1089\/scd.2020.0037","journal-title":"Stem Cells and Development"},{"issue":"1","key":"10990_CR99","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13287-020-01870-w","volume":"11","author":"E Ozmert","year":"2020","unstructured":"Ozmert, E., & Arslan, U. (2020). Management of retinitis pigmentosa by wharton\u2019s jelly-derived mesenchymal stem cells: Prospective analysis of 1-year results. Stem Cell Research & Therapy, 11(1), 353. https:\/\/doi.org\/10.1186\/s13287-020-01870-w","journal-title":"Stem Cell Research & Therapy"},{"issue":"15","key":"10990_CR100","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.21037\/atm-20-4747","volume":"9","author":"I Ahmed","year":"2021","unstructured":"Ahmed, I., Johnston, R. J., & Singh, M. S. (2021). Pluripotent stem cell therapy for retinal diseases. Annals Of Translational Medicine, 9(15), 1279. https:\/\/doi.org\/10.21037\/atm-20-4747","journal-title":"Annals Of Translational Medicine"},{"issue":"1","key":"10990_CR101","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000492838","volume":"49","author":"X Gu","year":"2018","unstructured":"Gu, X., Yu, X., Zhao, C., et al. (2018). Efficacy and safety of autologous bone marrow mesenchymal stem cell transplantation in patients with diabetic retinopathy. Cell Physiology and Biochemistry, 49(1), 40\u201352. https:\/\/doi.org\/10.1159\/000492838","journal-title":"Cell Physiology and Biochemistry"},{"issue":"1","key":"10990_CR102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10633-021-09817-z","volume":"143","author":"C Vilela","year":"2021","unstructured":"Vilela, C., Messias, A., Calado, R. T., et al. (2021). Retinal function after intravitreal injection of autologous bone marrow-derived mesenchymal stromal cells in advanced glaucoma. Documenta Ophthalmologica, 143(1), 33\u201338. https:\/\/doi.org\/10.1007\/s10633-021-09817-z","journal-title":"Documenta Ophthalmologica"},{"issue":"11","key":"10990_CR103","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4252\/wjsc.v8.i11.376","volume":"8","author":"S Labrador-Velandia","year":"2016","unstructured":"Labrador-Velandia, S., Alonso-Alonso, M. L., Alvarez-Sanchez, S., et al. (2016). Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials. World Journal of Stem Cells, 8(11), 376\u2013383. https:\/\/doi.org\/10.4252\/wjsc.v8.i11.376","journal-title":"World Journal of Stem Cells"},{"key":"10990_CR104","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.exer.2018.07.019","volume":"177","author":"S Bobba","year":"2018","unstructured":"Bobba, S., Di Girolamo, N., Munsie, M., et al. (2018). The current state of stem cell therapy for ocular disease. Experimental Eye Research, 177, 65\u201375. https:\/\/doi.org\/10.1016\/j.exer.2018.07.019","journal-title":"Experimental Eye Research"},{"issue":"9","key":"10990_CR105","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.18240\/ijo.2022.09.17","volume":"15","author":"K Sotiropulos","year":"2022","unstructured":"Sotiropulos, K., Kourkoutas, D., Almaliotis, D., et al. (2022). Ocular stem cells: A narrative review of current clinical trials. International Journal of Ophthalmology, 15(9), 1529\u20131537. https:\/\/doi.org\/10.18240\/ijo.2022.09.17","journal-title":"International Journal of Ophthalmology"},{"issue":"11","key":"10990_CR106","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","volume":"376","author":"AE Kuriyan","year":"2017","unstructured":"Kuriyan, A. E., Albini, T. A., Townsend, J. H., et al. (2017). Vision loss after intravitreal injection of autologous stem cells for age-related macular degeneration. New England Journal of Medicine, 376(11), 1047\u20131053. https:\/\/doi.org\/10.1056\/NEJMoa1609583","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10990_CR107","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"MS Mehat","year":"2018","unstructured":"Mehat, M. S., Sundaram, V., Ripamonti, C., et al. (2018). Transplantation of human embryonic stem cell-derived retinal pigment epithelium in macular degeneration. Nature Biotechnology, 36(4), 328\u2013337. https:\/\/doi.org\/10.1038\/nbt.4114","journal-title":"Nature Biotechnology"},{"issue":"Suppl 1","key":"10990_CR108","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/IAE.0000000000002575","volume":"39","author":"MA Zarbin","year":"2019","unstructured":"Zarbin, M. A., Montemagno, C., & Leary, J. F. (2019). Cell-based therapy for retinal degenerative disease: Clinical trials and regulatory issues. Retina (Philadelphia, Pa.), 39(Suppl 1), S8\u2013S23. https:\/\/doi.org\/10.1097\/IAE.0000000000002575","journal-title":"Retina (Philadelphia, Pa.)"},{"issue":"7647","key":"10990_CR109","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/543014a","volume":"543","author":"S Reardon","year":"2017","unstructured":"Reardon, S. (2017). Unproven stem cell therapy blinds patients. Nature, 543(7647), 14. https:\/\/doi.org\/10.1038\/543014a","journal-title":"Nature"},{"issue":"1","key":"10990_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stemcr.2015.11.013","volume":"6","author":"H Shirai","year":"2016","unstructured":"Shirai, H., Mandai, M., Matsushita, K., et al. (2016). Transplantation of human iPSC-derived retinal tissues in a primate model of exudative age-related macular degeneration. Stem Cell Reports, 6(1), 1\u201313. https:\/\/doi.org\/10.1016\/j.stemcr.2015.11.013","journal-title":"Stem Cell Reports"},{"key":"10990_CR111","doi-asserted-by":"publisher","unstructured":"Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., \u2026 Yamanaka, S. (2019).Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell, 24(4), 566\u2013578.e7. https:\/\/doi.org\/10.1016\/j.stem.2019.02.005.","DOI":"10.1016\/j.stem.2019.02.005."},{"issue":"7","key":"10990_CR112","doi-asserted-by":"publisher","first-page":"100674","DOI":"10.1016\/j.xcrm.2022.100674","volume":"3","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Sun, X., & Yu, C. (2022). Cell and gene therapy for retinal diseases: A comprehensive review. Cell Reports Medicine, 3(7), 100674. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100674","journal-title":"Cell Reports Medicine"},{"key":"10990_CR113","doi-asserted-by":"publisher","unstructured":"Grimaldi, A., Cesselli, D., Piscianz, E., Andriolo, G., Marzinotto, S., Comar, M.,\u2026 Giordano, A. (2019). Eye drop exosome-loaded extracellular vesicles from mesenchymal stem cells restore the lacrimal functional unit in a mouse model of dry eye. Stem Cell Research & Therapy, 10(1), 94. https:\/\/doi.org\/10.1186\/s13287-019-1195-6","DOI":"10.1186\/s13287-019-1195-6"},{"key":"10990_CR114","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","volume":"27","author":"JA Sahel","year":"2021","unstructured":"Sahel, J. A., Boulanger-Scemama, E., Pagot, C., Arleo, A., Galluppi, F., Martel, J. N., Esposti, Simona Degli, Delaux, Alexandre, de Saint Aubert, Jean-Baptiste., de Montleau, Caroline, Gutman, Emmanuel, Audo, Isabelle, Duebel, Jens, Picaud, Serge, Dalkara, Deniz, Blouin, Laure, Taiel, Magali, & Roska, B. (2021). Partial recovery of visual function in a blind patient after optogenetic therapy. Nature Medicine, 27, 1223\u20131229. https:\/\/doi.org\/10.1038\/s41591-021-01351-4","journal-title":"Nature Medicine"},{"key":"10990_CR115","doi-asserted-by":"publisher","first-page":"638685","DOI":"10.3389\/fcell.2021.638685","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Zhao, J., Li, J., Zhao, Y., Yang, W., & Peng, J. (2021). Advances in imaging-guided stem cell transplantation for retinal degeneration. Frontiers in Cell and Developmental Biology, 9, 638685. https:\/\/doi.org\/10.3389\/fcell.2021.638685","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10990_CR116","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.scr.2017.09.010","volume":"24","author":"M Munsie","year":"2017","unstructured":"Munsie, M., & Hyun, I. (2017). A question of ethics: Selling autologous stem cell therapies flaunts professional standards. Stem Cell Research, 24, 162\u2013168. https:\/\/doi.org\/10.1016\/j.scr.2017.09.010","journal-title":"Stem Cell Research"},{"key":"10990_CR117","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., et al. (2021). Age-related macular degeneration. Nature Reviews Disease Primers, 7, 31. https:\/\/doi.org\/10.1038\/s41572-021-00265-2","journal-title":"Nature Reviews Disease Primers"},{"key":"10990_CR118","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","volume":"66","author":"SK Verbakel","year":"2018","unstructured":"Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., et al. (2018). Non-syndromic retinitis pigmentosa. Progress in Retinal and Eye Research, 66, 157\u2013186. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.03.005","journal-title":"Progress in Retinal and Eye Research"},{"issue":"3","key":"10990_CR119","doi-asserted-by":"publisher","first-page":"949","DOI":"10.4103\/ijo.IJO_2781_22","volume":"71","author":"HS Dua","year":"2023","unstructured":"Dua, H. S., Saini, J. S., Azuara-Blanco, A., & Gupta, P. (2023). Limbal stem cell deficiency: Concept, aetiology, clinical presentation, diagnosis and management. Indian Journal of Ophthalmology, 71(3), 949\u2013962. https:\/\/doi.org\/10.4103\/ijo.IJO_2781_22","journal-title":"Indian Journal of Ophthalmology"},{"issue":"11","key":"10990_CR120","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology, 121(11), 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"issue":"10","key":"10990_CR121","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11892-022-01491-y","volume":"22","author":"JA Zehden","year":"2022","unstructured":"Zehden, J. A., Mortensen, X. M., Reddy, A., & Zhang, A. Y. (2022). Systemic and ocular adverse events with intravitreal anti-VEGF therapy used in the treatment of diabetic retinopathy: A review. Current Diabetes Reports, 22(10), 525\u2013536. https:\/\/doi.org\/10.1007\/s11892-022-01491-y","journal-title":"Current Diabetes Reports"},{"issue":"Suppl1","key":"10990_CR122","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","volume":"53","author":"A Alm","year":"2008","unstructured":"Alm, A., Grierson, I., & Shields, M. B. (2008). Side effects associated with prostaglandin analog therapy. Survey of Ophthalmology, 53(Suppl1), S93\u2013S105. https:\/\/doi.org\/10.1016\/j.survophthal.2008.08.004","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10990_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14740338.6.1.45","volume":"6","author":"G Holl\u00f3","year":"2007","unstructured":"Holl\u00f3, G. (2007). The side effects of the prostaglandin analogues. Expert Opinion on Drug Safety, 6(1), 45\u201352. https:\/\/doi.org\/10.1517\/14740338.6.1.45","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10990_CR124","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13287-018-1091-y","volume":"9","author":"C Jin","year":"2018","unstructured":"Jin, C., Ou, Q., Li, Z., Wang, J., Zhang, J., Tian, H., Xu, J. Y., Gao, F., Lu, L., & Xu, G. T. (2018). The combination of bFGF and CHIR99021 maintains stable self-renewal of mouse adult retinal progenitor cells. Stem Cell Research & Therapy, 9(1), 346. https:\/\/doi.org\/10.1186\/s13287-018-1091-y","journal-title":"Stem Cell Research & Therapy"},{"issue":"8","key":"10990_CR125","doi-asserted-by":"publisher","first-page":"e43797","DOI":"10.1371\/journal.pone.0043797","volume":"7","author":"G Rodr\u00edguez-Mart\u00ednez","year":"2012","unstructured":"Rodr\u00edguez-Mart\u00ednez, G., Molina-Hern\u00e1ndez, A., & Velasco, I. (2012). Activin A promotes neuronal differentiation of cerebrocortical neural progenitor cells. PLoS One, 7(8), e43797. https:\/\/doi.org\/10.1371\/journal.pone.0043797","journal-title":"PLoS One"},{"issue":"6","key":"10990_CR126","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4252\/wjsc.v15.i6.548","volume":"15","author":"Y Peng","year":"2023","unstructured":"Peng, Y., Jiang, H., & Zuo, H. D. (2023). Factors affecting osteogenesis and chondrogenic differentiation of mesenchymal stem cells in osteoarthritis. World Journal of Stem Cells, 15(6), 548\u2013560. https:\/\/doi.org\/10.4252\/wjsc.v15.i6.548","journal-title":"World Journal of Stem Cells"},{"issue":"1","key":"10990_CR127","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.celrep.2016.08.078","volume":"17","author":"K Yao","year":"2016","unstructured":"Yao, K., Qiu, S., Tian, L., Snider, W. D., Flannery, J. G., Schaffer, D. V., & Chen, B. (2016). Wnt regulates proliferation and neurogenic potential of M\u00fcller glial cells via a Lin28\/let-7 miRNA-dependent pathway in adult mammalian retinas. Cell Reports, 17(1), 165\u2013178. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.078","journal-title":"Cell Reports"},{"key":"10990_CR128","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9208173","volume":"2019","author":"C Peng","year":"2019","unstructured":"Peng, C., Li, Y., Lu, L., Zhu, J., Li, H., & Hu, J. (2019). Efficient one-step induction of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) produces MSC-derived neurospheres (MSC-NS) with unique transcriptional profile and enhanced neurogenic and angiogenic secretomes. Stem Cells International, 2019, Article 9208173. https:\/\/doi.org\/10.1155\/2019\/9208173","journal-title":"Stem Cells International"},{"issue":"1","key":"10990_CR129","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12964-020-00650-6","volume":"18","author":"K Asgarpour","year":"2020","unstructured":"Asgarpour, K., Shojaei, Z., Amiri, F., Ai, J., Mahjoubin-Tehran, M., Ghasemi, F., ArefNezhad, R., Hamblin, M. R., & Mirzaei, H. (2020). Exosomal MicroRNAs derived from mesenchymal stem cells: Cell-to-cell messages. Cell Communication and Signaling, 18(1), 149. https:\/\/doi.org\/10.1186\/s12964-020-00650-6","journal-title":"Cell Communication and Signaling"},{"key":"10990_CR130","doi-asserted-by":"publisher","first-page":"e1049","DOI":"10.14806\/ej.29.0.1049","volume":"29","author":"E Papakonstantinou","year":"2024","unstructured":"Papakonstantinou, E., Dragoumani, K., Chrousos, G. P., & Vlachakis, D. (2024). Exosomal Epigenetics EMBnet Journal, 29, e1049. https:\/\/doi.org\/10.14806\/ej.29.0.1049.","journal-title":"Exosomal Epigenetics EMBnet Journal"},{"issue":"6","key":"10990_CR131","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1097\/JS9.0000000000002377","volume":"111","author":"Y Cai","year":"2025","unstructured":"Cai, Y., & Zhou, Q. (2025). Stem cell therapy in ophthalmology: Emerging clinical trials and regulatory developments. International Journal of Surgery (London England), 111(6), 4050\u20134052. https:\/\/doi.org\/10.1097\/JS9.0000000000002377","journal-title":"International Journal of Surgery (London England)"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10990-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:02:35Z","timestamp":1768341755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10990-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10990"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10990-w","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical Trial Number: Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"Human participants or animal experiments were not used in this study. Hence approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}